PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-20

Study Completion Date

2020-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Whether the perceived changes in management of Acute Severe Ulcerative Colitis during the COVID pandemic are widespread, and whether they have any impact on patient outcomes

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC)

NCT03907631

Severe Ulcerative Colitis

ACTIVE_NOT_RECRUITING

Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis

NCT02922374

Acute Severe Colitis (ASC)

UNKNOWN PHASE1/PHASE2

Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)

NCT03669822

Ulcerative Colitis

COMPLETED

MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.

NCT04272307

Inflammatory Bowel Diseases Colitis Ulcerative

UNKNOWN

PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic

NCT04410484

Inflammatory Bowel Diseases Coronavirus Infection

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study aims to evaluate the process, evaluation and therapy variation in management of ASUC with reference to 2019 British Society of Gastroenterology guidelines and see whether there are any differences between ambulatory and hospital management in ASUC. Also to evaluate the outcomes in ASUC patients managed during the COVID-19 pandemic

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Diseases COVID

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Main group

Patient with Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index managed during the study period

No interventions assigned to this group

Control Group

Patients with ASUC managed in the unit from 1st Jan to 31st June 2019

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 16 -100 inclusive
* Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index managed during the study period

Exclusion Criteria

* Patients aged 16 -100 inclusive
* Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index managed during the study period

* Admission for elective colectomy
* Pouch or stoma

Minimum Eligible Age

16 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No